Incidence, clinical features and diagnosis of cicatrising conjunctivitis in Australia and New Zealand
Open Access
- 19 June 2018
- journal article
- research article
- Published by Springer Nature in Eye
- Vol. 32 (10) , 1636-1643
Abstract
This study aimed to determine the incidence, clinical features and management of cicatrising conjunctivitis in Australia and New Zealand, also enabling comparison with data from the United Kingdom. A prospective surveillance study was conducted over 17 months via the Australian and New Zealand Ophthalmic Surveillance Unit with a one-year follow-up period. Practicing ophthalmologists on the Surveillance Unit’s database were asked to report recently diagnosed cases of cicatrising conjunctivitis on a monthly basis. Initial and follow-up questionnaires were sent to ophthalmologists who had reported positive cases to obtain demographic and clinical data. The minimum incidence of cicatrising conjunctivitis was calculated based on cases reported during the study period and from population data. During the 17-month study period (December 2011–April 2013), 56 cases of cicatrising conjunctivitis were reported. Data was obtained for 35 cases (62%) with a mean age of 74 years (range, 28–94 years). The most common aetiologies were ocular mucus membrane pemphigoid (n = 18 cases, 51.4%), Stevens–Johnson Syndrome (n = 3, 8.6%) and graft versus host disease (n = 3, 8.6%). The minimum incidence of cicatrising conjunctivitis in Australia and New Zealand was 1.5 per million, comparable to incidence data from the United Kingdom. This study is the first to prospectively record the incidence of cicatrising conjunctivitis in Australia and New Zealand and the second worldwide. It provides novel data on demographics and management of cicatrising conjunctivitis, as reported by treating ophthalmologists.Keywords
This publication has 23 references indexed in Scilit:
- Incidence, presenting features, and diagnosis of cicatrising conjunctivitis in the United KingdomEye, 2012
- Evaluation of early and late presentation of patients with ocular mucous membrane pemphigoid to two major tertiary referral hospitals in the United KingdomEye, 2011
- Treatment of Ocular Mucous Membrane Pemphigoid with Immunosuppressive Drug TherapyOphthalmology, 2008
- Stevens‐Johnson syndrome: Pathogenesis, diagnosis, and managementAnnals of Medicine, 2008
- Mucous membrane pemphigoid and pseudopemphigoidOphthalmology, 2004
- The British Ophthalmological Surveillance Unit: an evaluation of the first 3 yearsEye, 2003
- Progression of disease in ocular cicatricial pemphigoid.British Journal of Ophthalmology, 1996
- Chronic progressive conjunctival cicatrisationEye, 1993
- Systemic Chemotherapy for Ocular Cicatricial PemphigoidCornea, 1991
- Immunofluorescent studies in ocular cicatricial pemphigoidBritish Journal of Dermatology, 1988